Susie Lisa
Senior Vice President, Investor Relations
Replay available
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2025 Earnings Call
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2025 earnings conference call, held 2025-11-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Reshma Kewal Ramani
CEO and President
Duncan McKechnie
Chief Commercial Officer
Charlie Wagner
Chief Operating and Financial Officer
Jeff Meacham
Analyst, Citibank
Talveen Richter
Analyst, Goldman Sachs
Jessica Fye
Analyst, J.P. Morgan
Evan Siegerman
Analyst, VMO Capital
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vertex Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:01.634 -- 00:00:07.362 Good day and welcome to the Vertex Pharmaceuticals third quarter of 2025 earnings call. 00:00:07.362 -- 00:00:09.705 All participants will be in a listen-only mode. 00:00:09.705 -- 00:00:13.330 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.330 -- 00:00:15.714 key followed by zero. 00:00:15.714 -- 00:00:19.459 After today's presentation, there will be an opportunity to ask questions. 00:00:19.459 -- 00:00:23.184 Please note this event is being recorded. I would now like to turn the conference over 00:00:23.184 -- 00:00:27.107 to Ms. Susie Lisa. Please go ahead, ma'am. 00:00:27.925 -- 00:00:32.792 good evening all my name is susie lisa and as the senior vice president of investor relations 00:00:32.792 -- 00:00:37.379 it is my pleasure to welcome you to our third quarter 2025 financial results conference 00:00:37.379 -- 00:00:42.867 call on tonight's call making prepared remarks we have dr reishma kewal ramani vertex's 00:00:42.867 -- 00:00:47.814 ceo and president duncan mckechnie chief commercial officer and charlie wagner chief 00:00:47.814 -- 00:00:52.160 operating and financial officer we recommend that you access the webcast slides as you 00:00:52.160 -- 00:00:56.386 listen to this call the call is being recorded and a replay will be available on our 00:00:56.386 -- 00:01:00.511 website We will make forward-looking statements on this call that are subject to the 00:01:00.511 -- 00:01:05.377 risks and uncertainties discussed in detail in today's press release and in our filings 00:01:05.377 -- 00:01:07.559 with the Securities and Exchange Commission. 00:01:07.559 -- 00:01:12.405 These statements, including without limitation those regarding Vertex's marketed medicines 00:01:12.40...